Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bruce Verchere

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
ACS Synthetic Biology|December 26, 2024
Advances in Engineering Myeloid Cells for Cell Therapy ApplicationsBruno F A Freitas, C Bruce Verchere, Megan K Levings
Biotechniques|May 20, 2006
Application of in situ ductal perfusion to facilitate isolation of high-quality RNA from mouse pancreasAnne E Mullin, Galina Soukatcheva, C Bruce Verchere, et al.
The Journal of Biological Chemistry|January 21, 2016
Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) AggregatesClara Westwell-Roper, Heather C Denroche, Jan A Ehses, et al.
Diabetes Care|January 23, 2019
Probing the Meaning of Persistent Propeptide Release in Type 1 DiabetesSteven E Kahn, Andrew T Templin, Rebecca L Hull, et al.
Islets|November 25, 2010
Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasisMeredith J H Hutton, Galina Soukhatcheva, James D Johnson, et al.
Diabetes|August 27, 2005
The X-linked inhibitor of apoptosis protein enhances survival of murine islet allograftsAnnette Plesner, Peter Liston, Rusung Tan, et al.
Current Opinion in Lipidology|May 14, 2010
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitusJanine K Kruit, Liam R Brunham, C Bruce Verchere, et al.
The Journal of Clinical Investigation|February 5, 2008
Cholesterol in islet dysfunction and type 2 diabetesLiam R Brunham, Janine K Kruit, C Bruce Verchere, et al.
Biochemistry|August 17, 2010
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicityFanling Meng, Andisheh Abedini, Annette Plesner, et al.
Current Diabetes Reports|April 29, 2010
Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetesLiam R Brunham, Janine K Kruit, Michael R Hayden, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
ACS Synthetic Biology|December 26, 2024
Advances in Engineering Myeloid Cells for Cell Therapy ApplicationsBruno F A Freitas, C Bruce Verchere, Megan K Levings
Biotechniques|May 20, 2006
Application of in situ ductal perfusion to facilitate isolation of high-quality RNA from mouse pancreasAnne E Mullin, Galina Soukatcheva, C Bruce Verchere, et al.
The Journal of Biological Chemistry|January 21, 2016
Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) AggregatesClara Westwell-Roper, Heather C Denroche, Jan A Ehses, et al.
Diabetes Care|January 23, 2019
Probing the Meaning of Persistent Propeptide Release in Type 1 DiabetesSteven E Kahn, Andrew T Templin, Rebecca L Hull, et al.
Islets|November 25, 2010
Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasisMeredith J H Hutton, Galina Soukhatcheva, James D Johnson, et al.
Diabetes|August 27, 2005
The X-linked inhibitor of apoptosis protein enhances survival of murine islet allograftsAnnette Plesner, Peter Liston, Rusung Tan, et al.
Current Opinion in Lipidology|May 14, 2010
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitusJanine K Kruit, Liam R Brunham, C Bruce Verchere, et al.
The Journal of Clinical Investigation|February 5, 2008
Cholesterol in islet dysfunction and type 2 diabetesLiam R Brunham, Janine K Kruit, C Bruce Verchere, et al.
Biochemistry|August 17, 2010
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicityFanling Meng, Andisheh Abedini, Annette Plesner, et al.
Current Diabetes Reports|April 29, 2010
Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetesLiam R Brunham, Janine K Kruit, Michael R Hayden, et al.
Pageof 14